Smartleaf Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Smartleaf Asset Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-142	Closed	-$4.54K	–	3048
2024 Q3	$4.54K	Buy	+142	New	+$4.89K	﹤0.01%	2166

Smartleaf Asset Management's LBPH Position: Q4 2024 in Review

Smartleaf Asset Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 142 shares — an estimated $4.54K sold.

Smartleaf Asset Management first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $4.54K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Smartleaf Asset Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Smartleaf Asset Management sold 142 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $4.54K.
Smartleaf Asset Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Smartleaf Asset Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $4.54K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Smartleaf Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.